Car-T Cell Therapy: A Paradigm Shift in Cancer Treatment
Journal of Drug Delivery and Therapeutics · 15.03.2026 · 16 (3) · 192-199
DOI: 10.22270/jddt.v16i3.7599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.03.2026. Verfasst von Pratiksha Hajare und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chimeric antigen receptor T-cell (CAR-T) therapy, a major application of precision and customized medicine, has emerged as a revolutionary advancement in cancer immunotherapy. CAR-T therapy genetically alters a patient's T cells to express synthetic receptors that accurately identify tumor-associated antigens in an MHC-independent manner, resulting in potent and targeted anticancer activity. This study provides an overview of the fundamental ideas of CAR-T cell therapy, including T-cell biology, CAR structure and generations, and the production process, which includes leukapheresis, genetic engineering, ex vivo expansion, conditioning chemotherapy, and patient injection. The mechanisms underlying CAR-T-mediated tumor destruction include antigen recognition, T-cell activation, cytotoxic effector pathways, cytokine production, and tumor lysis. We examine the most recent FDA-approved CAR-T treatments and their clinical applications. We also discuss novel applications in solid tumors and associated issues, such as immune-suppressive tumor microenvironment and antigen heterogeneity. The primary adverse effects, such as immune effector cell-associated neurotoxicity syndrome and cytokine release syndrome, are also discussed in the review along with current treatments. Finally, the drawbacks of CAR-T therapy, recent advances in technology, and the evolving CAR-T environment in India including domestic innovations are examined. Keywords: Tumor; Cancer immunotherapy; Precision medicine; Cytokine release syndrom
Zitieren
APA
Hajare, P., Lokhande, R. S., Game, N. S., & Patki, S. P. (2026). Car-T Cell Therapy: A Paradigm Shift in Cancer Treatment. Journal of Drug Delivery and Therapeutics, 16(3), 192-199. https://doi.org/10.22270/jddt.v16i3.7599
Vancouver
Hajare P, Lokhande RS, Game NS, Patki SP. Car-T Cell Therapy: A Paradigm Shift in Cancer Treatment. Journal of Drug Delivery and Therapeutics. 2026;16(3):192-199. doi:10.22270/jddt.v16i3.7599
BibTeX
@article{Hajare2026,
author = {Hajare, Pratiksha and Lokhande, Rachana Satish and Game, Nikita Sarjerao and Patki, Shatakshi Prakash},
title = {Car-T Cell Therapy: A Paradigm Shift in Cancer Treatment},
journal = {Journal of Drug Delivery and Therapeutics},
year = {2026},
volume = {16},
number = {3},
pages = {192--199},
doi = {10.22270/jddt.v16i3.7599}
}
EUVIMED